Anifrolumab Malignancy and Serious Infections Study

NCT07000110 · clinicaltrials.gov ↗

RECRUITING

Status

3195

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Anifrolumab

Sponsor

AstraZeneca

Collaborators

[object Object]